Ola Bratt (Former)
61 – 70 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
(
- Contribution to journal › Article
-
Mark
Extended pelvic lymphadenectomy for prostate cancer: Will the previously reported benefits be reproduced in hospitals with lower surgical volumes?
(
- Contribution to journal › Article
- 2008
-
Mark
Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden
(
- Contribution to journal › Article
-
Mark
Socialstyrelsens riktlinjer för prostatacancersjukvården. Hälsokontroll med PSA-test--bara för välinformerade män.
(
- Contribution to journal › Article
- 2007
-
Mark
What should a urologist know about hereditary predisposition to prostate cancer?
(
- Contribution to journal › Scientific review
-
Mark
The urologist's guide to low dose-rate interstitial brachytherapy with permanent seed implants for localized prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
Prostataspecifikt antigen--den viktigaste cancermarkören. Diagnostik och uppföljning av prostatacancer har förändrats markant.
(
- Contribution to journal › Article
-
Mark
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
(
- Contribution to journal › Article
- 2006
-
Mark
CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden
(
- Contribution to journal › Article
-
Mark
The difficult case in prostate cancer diagnosis - When is a "diagnostic TURP" indicated?
(
- Contribution to journal › Debate/Note/Editorial